Openstream.ai's Digital Twin Revolution, Biopharma AI Breakthroughs, AI in Healthcare, and Novo's Billion Dollar Cardiac Deal

AI in Life Sciences

Content provided by Stan Berteloot. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stan Berteloot or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4M ago 2:51

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 08, 2024 07:55 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

On the latest episode of "AI in Life Sciences," we engage with the impressive multimodal, AI-driven technology patented by Openstream.ai. This technology promises to revolutionize operational efficiency across multiple sectors with its advanced capabilities. Also, we discuss a breakthrough in the biopharma industry - an AI platform capable of identifying promising early-stage assets and firms. We also delve into the pressing need for the integration of AI technology in the healthcare sector for improved patient care and operational efficiency. We round up the episode examining the implications of Novo's $1 billion deal in the field of cardiovascular medicine, a move that could redefine the cardiac treatment landscape. Tune in for these exciting insights and more.

17 episodes

#Science #Biology #News #Tech News #Stan Berteloot #Technology #Pharma